Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

It’s Complicated

| Maryam Mahdi

Novo Nordisk's Stephen Gough explains how pharma can address the cardiovascular risks associated with type 2 diabetes.

Discovery & Development Drug Discovery

Diabetes: Finding a Panacea

| Maryam Mahdi

How can we effectively manage the treatment of type 1 diabetes?

Discovery & Development Contract Manufacturing Services

Getting a Handle on High Potency

| Maryam Mahdi

How can companies avoid the risks of HPAPI containment and handling?

Discovery & Development Drug Discovery

Mass Spec Meets Machine learning

| Stephanie Vine

Can machine learning offer mass spectrometry a boost for drug discovery?

Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Discovery & Development Drug Discovery

Poisoning Pain

| Maryam Mahdi

Exploring a new approach to treating IBS pain.

Discovery & Development Drug Discovery

The Gut Response

| Maryam Mahdi

In what ways can the microbiome interact with oral medicines?

Discovery & Development Drug Delivery

The Long and Short of It

| Robert W. Lee

Why drug developers should take a fresh look at long-acting dosage forms.

Discovery & Development Drug Discovery

Does AI Dream of Electric Patents?

| Amy Nick

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.

Discovery & Development Clinical Trials

A Matter of Trust

| Maryam Mahdi

Can we trust the integrity of clinical trials?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register